Jury Gives Defense Verdict in 2nd Xarelto Trial
On Monday, a jury came out with a defense verdict in the second trial over the blood thinner. That's about a month after Johnson & Johnson and Bayer won the first bellwether trial over Xarelto.
This month's trial, which began on May 30, involved a case brought by the husband and children of Sharyn Orr, who died from a hemorrhagic stroke in 2015 after taking Xarelto for one year.
In the first trial, jurors deliberated for less than two hours before rendering their verdict on May 3. This time, the jury deliberated for about three hours.
More than 16,000 cases have been filed alleging that Xarelto, an anticoagulant used to treat blood clots and prescribed for atrial fibrillation, has caused uncontrollable internal bleeding in patients. Monday's verdict comes in the second of four bellwether trials scheduled before U.S. District Judge Eldon Fallon of the Eastern District of Louisiana.
In a statement, lead plaintiffs' counsel Brian Barr and Andy Birchfield insisted the third trial would go their way.
Read the full article here.